Please login to the form below

Not currently logged in
Email:
Password:

Newron Pharma

This page shows the latest Newron Pharma news and features for those working in and with pharma, biotech and healthcare.

Newron back on track for Xadago approval in US

Newron back on track for Xadago approval in US

Newron Pharma will not have to conduct any additional clinical trials for its Parkinson's disease drug Xadago in the US, setting up a new FDA filing in the coming weeks. ... Now, Newron is planning to refile a marketing application with the FDA in

Latest news

  • Rare disease therapies head the ‘class of 2015’ Rare disease therapies head the ‘class of 2015’

    maintaining the high output from pharma industry pipelines of the last few years. ... neprilysin inhibitor. Novartis. USA. safinamide. Xadago. Parkinson's disease. MAO-B inhibitor. Newron Pharma.

  • Chasing the cure for Parkinson's disease Chasing the cure for Parkinson's disease

    Generic versions of this drug combination are also available, including Parcopa (Azur Pharma). ... Currently available therapies of this class include selegiline and rasagiline. Safinamide (Newron, Zambon and Meiji Seika Pharma) is a selective and

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Newron Pharma appoints commercial affairs VP Newron Pharma appoints commercial affairs VP

    Dennis Dionne brings expertise from J&J and Novartis. Milan, Italy-based Newron Pharmaceuticals has promoted Dennis Dionne to vice president of commercial affairs. ... Stefan Weber, chief executive officer of Newron, said: “We sincerely thanks Anders

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics